Cancer (chemotherapy) drugs in shortage

These chemotherapy drugs are currently on the FDA shortage list. Click one for its per-manufacturer, per-strength record and a change-only email alert. This is a curated list of cancer drugs; the FDA's own therapeutic category is Oncology.

Shortages of chemotherapy drugs are especially serious because there is often no interchangeable alternative, and treatment delays can affect outcomes. Carboplatin and methotrexate — two of the most widely used cancer drugs — have been in recurring shortage. The FDA's shortage list is the official national record of which manufacturers and strengths are affected; it is not your hospital's or pharmacy's stock. Always confirm with your oncology team, and see what to do if your medication is in shortage.

Azacitidine Injection also: Azacitidine, Vidaza Unavailable 3Limited 1Available 5 9 manufacturers, 9 FDA-listed presentations Carboplatin Injection also: Carboplatin, Kyxata Unavailable 14Limited 9Available 4Not specified 4 9 manufacturers, 31 FDA-listed presentations Ifosfamide Injection also: Ifex, Ifosfamide Unavailable 4Limited 1Available 3 4 manufacturers, 8 FDA-listed presentations Methotrexate Sodium Injection also: Methotrexate Unavailable 4Limited 3Available 7 5 manufacturers, 14 FDA-listed presentations Pentostatin Injection also: Nipent Unavailable 1 1 manufacturers, 1 FDA-listed presentations Streptozocin Powder, For Solution Unavailable 1Available 1 2 manufacturers, 2 FDA-listed presentations

This is the FDA's national supply record, not your pharmacy's shelf. A manufacturer listed "Available" can still be out of stock locally; ask your pharmacist. See what to do if your medication is in shortage.

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).